Genetic background determines mouse strain differences in inflammatory angiogenesis.

Inflammation and angiogenesis are key components of fibrovascular tissue growth, a biological event underlying both physiological (wound healing) and pathological conditions (tumor development, chronic inflammation). We investigated these components in three frequently used mouse strains (Swiss, Balb/c and C57BL/6J) to verify the influence of genetic background on the kinetics of inflammatory cell recruitment/activation, neovascularization, extracellular matrix deposition, and cytokine production in polyether-polyurethane sponge implanted subcutaneously in male mice of these strains. The kinetics of neutrophil recruitment/activation as assessed by myeloperoxidase (MPO) activity was 2- and 3-fold higher in Balb/c implants at day 1 compared with Swiss and C57BL/6J implants, respectively. Macrophage accumulation/activation as NAG (n-acetyl β-glucosaminidase) activity was higher in Swiss implants. The levels the monocyte chemoattractant protein 1 (CCL2(MCP-1)) peaked at day 10 in the three types of implants but was produced more by C57BL/6J mice. Angiogenesis (hemoglobin, vascular endothelial growth factor-VEGF, and number of vessels) differed among the strains. Swiss implants had the highest hemoglobin content but the lowest VEGF levels. In contrast, Balb/c implants had higher VEGF levels but lower hemoglobin. Collagen deposition and transforming growth factor β-1; TGFβ-1 levels also varied among the groups. Swiss and Balb/c implants had progressive increase in TGFβ-1 from 4 to 14 days, while C57BL/6J implants achieved the peak at day 10 and fell at day 14. These findings emphasize the major contribution of genetic background in the temporal pattern and intensity of inflammatory angiogenesis components that may have functional consequences in physiological and pathological conditions where these processes co-exist.

[1]  S. Leal,et al.  Genetic variation responsible for mouse strain differences in integrin alpha 2 expression is associated with altered platelet responses to collagen. , 2004, Blood.

[2]  R. Clark,et al.  Cutaneous tissue repair: practical implications of current knowledge. II. , 1985, Journal of the American Academy of Dermatology.

[3]  Jack Gauldie,et al.  TGF-β and Smad3 Signaling Link Inflammation to Chronic Fibrogenesis1 , 2005, The Journal of Immunology.

[4]  M. Teixeira,et al.  Sponge‐induced angiogenesis and inflammation in PAF receptor‐deficient mice (PAFR‐KO) , 2004, British journal of pharmacology.

[5]  Andrew Leask,et al.  TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  G. Andrés,et al.  Inflammatory cells and chemokines sustain FGF2-induced angiogenesis. , 2009, European cytokine network.

[7]  D. Pomp,et al.  Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. , 2007, Physiological genomics.

[8]  F. Liu,et al.  Genetic heterogeneity of skin microvasculature. , 2010, Developmental biology.

[9]  Y. S. Bakhle,et al.  Mechanisms of wound healing responses in lupus‐prone New Zealand White mouse strain , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[10]  D. Hinton,et al.  Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization , 2005, Laboratory Investigation.

[11]  J. LaManna,et al.  Cerebral angiogenic factors, angiogenesis, and physiological response to chronic hypoxia differ among four commonly used mouse strains. , 2007, Journal of applied physiology.

[12]  L. Donehower,et al.  Effects of genetic background on tumorigenesis in p53‐deficient mice , 1995, Molecular carcinogenesis.

[13]  Jian Li,et al.  Hypoxia-regulated angiogenic inhibitors. , 2009, Trends in cardiovascular medicine.

[14]  C. Sigmund.  Viewpoint: are studies in genetically altered mice out of control? , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  S. Werner,et al.  Wound-healing studies in transgenic and knockout mice , 2004, Molecular biotechnology.

[16]  R. D'Amato,et al.  Genetic heterogeneity of angiogenesis in mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  M. Manigrasso,et al.  Comparison of Fracture Healing Among Different Inbred Mouse Strains , 2008, Calcified Tissue International.

[18]  T. Fan,et al.  Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[19]  K. Sugamura,et al.  Constitutive OX40/OX40 Ligand Interaction Induces Autoimmune-Like Diseases1 , 2002, The Journal of Immunology.

[20]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.

[21]  M. Burdick,et al.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. , 2004, The Journal of clinical investigation.

[22]  A. Tarkowski,et al.  Outcome of Staphylococcus aureus ‐triggered sepsis and arthritis in IL‐4‐deficient mice depends on the genetic background of the host , 1999, European journal of immunology.

[23]  S. Kahn,et al.  Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. , 2005, The Journal of endocrinology.

[24]  Ann Richmond,et al.  Chemokines in health and disease. , 2011, Experimental cell research.

[25]  P. Sime,et al.  Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. , 2002, American journal of respiratory cell and molecular biology.

[26]  R. Gamelli,et al.  Is impaired wound healing caused by infection or nutritional depletion? , 1987, Surgery.

[27]  A. C. Collins,et al.  Decreased ethanol sensitivity and tolerance development in gamma-protein kinase C null mutant mice is dependent on genetic background. , 1999, Alcoholism, clinical and experimental research.

[28]  S. Andrade,et al.  Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice. , 2009, Microvascular research.

[29]  Napoleone Ferrara,et al.  Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective , 2006, Clinical Cancer Research.

[30]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[31]  J. Zieske,et al.  BALB/c and C57BL6 mouse strains vary in their ability to heal corneal epithelial debridement wounds. , 2008, Experimental eye research.

[32]  S. Andrade,et al.  Sponge-induced angiogenesis in mice and the pharmacological reactivity of the neovasculature quantitated by a fluorimetric method. , 1997, Microvascular research.

[33]  D. Willoughby,et al.  The codependence of angiogenesis and chronic inflammation , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  M. Reed,et al.  Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC‐null mice , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[35]  Subburaman Mohan,et al.  New quantitative trait loci that regulate wound healing in an intercross progeny from DBA/1J and 129×1/SvJ inbred strains of mice , 2006, Functional & Integrative Genomics.

[36]  Shizhong Xu,et al.  Genetic control of the rate of wound healing in mice , 2001, Heredity.

[37]  M. Daemen,et al.  Mouse strain determines the outcome of wound healing after myocardial infarction. , 2009, Cardiovascular research.